Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-19 Sale | 2024-03-19 8:57 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 15,515 | $39.22 | $608,498 | 97,939 (Direct) | View |
| 2024-02-12 Sale | 2024-02-13 8:50 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 1,918 | $50.8 | $97,441 | 90,171 (Direct) | View |
| 2024-02-01 Sale | 2024-02-05 6:54 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 1,616 | $45.06 | $72,817 | 89,990 (Direct) | View |
| 2023-12-05 Sale | 2023-12-07 4:16 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 27,026 | $38.72 | $1,046,360 | 303,594 (Direct) | View |
| 2023-11-24 Sale | 2023-11-28 4:05 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 10,974 | $35.02 | $384,336 | 199,526 (Direct) | View |
| 2023-11-14 Sale | 2023-11-16 4:05 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 12,000 | $30.38 | $364,573 | 210,500 (Direct) | View |
| 2023-02-14 Sale | 2023-02-14 8:59 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 702 | $26.87 | $18,863 | 64,093 (Direct) | View |
| 2023-02-09 Sale(A) | 2023-02-14 7:08 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 1,413 | $27.51 | $38,872 | 57,764 (Direct) | View |
| 2023-02-09 Sale | 2023-02-13 5:03 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 1,398 | $27.66 | $38,669 | 69,966 (Direct) | View |
| 2022-07-01 Sale | 2022-07-06 6:08 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 7,547 | $4.08 | $30,792 | 57,614 (Direct) | View |
| 2022-02-15 Sale | 2022-02-15 7:31 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 833 | $6.1 | $5,081 | 47,192 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-16 Option Award | 2024-02-21 7:01 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 140,550 | $0 | 220,254 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-13 8:50 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 6,407 | $0 | 90,171 (Direct) | View |
| 2024-02-01 Exercise | 2024-02-05 6:54 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 4,925 | $0 | 89,990 (Direct) | View |
| 2023-12-29 Exercise | 2024-01-03 4:15 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 10,500 | $6.88 | 172,500 (Direct) | View |
| 2023-12-29 Exercise | 2024-01-03 4:15 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 10,500 | $0 | 172,500 (Direct) | View |
| 2023-12-05 Exercise | 2023-12-07 4:16 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 27,026 | $6.88 | 303,594 (Direct) | View |
| 2023-12-05 Exercise | 2023-12-07 4:16 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 27,026 | $0 | 303,594 (Direct) | View |
| 2023-11-24 Exercise | 2023-11-28 4:05 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 10,974 | $6.88 | 199,526 (Direct) | View |
| 2023-11-24 Exercise | 2023-11-28 4:05 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 10,974 | $0 | 199,526 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 4:05 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 12,000 | $6.88 | 210,500 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 4:05 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 12,000 | $0 | 210,500 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-30 4:31 pm | N/A 2033-06-22 | Aeglea BioTherapeutics Inc. | AGLE | Smith Hunter C Director | 1,950,000 | $0 | 1,950,000 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 4:05 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 2,000 | $6.88 | 222,500 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 4:05 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 2,000 | $0 | 222,500 (Direct) | View |
| 2023-02-11 Exercise | 2023-02-14 8:59 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 2,344 | $0 | 64,093 (Direct) | View |
| 2023-02-09 Exercise | 2023-02-13 5:03 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 4,063 | $0 | 69,966 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:09 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 73,300 | $0 | 73,300 (Direct) | View |
| 2022-12-23 Gift | 2022-12-29 4:31 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 2,500 | $0 | 55,114 (Direct) | View |
| 2022-06-30 Exercise | 2022-07-06 6:08 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 25,000 | $0 | 57,614 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 9:19 pm | N/A 2032-06-06 | Aeglea BioTherapeutics Inc. | AGLE | Smith Hunter C Director | 43,000 | $0 | 43,000 (Direct) | View |
| 2022-02-11 Exercise | 2022-02-15 7:31 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 2,344 | $0 | 47,192 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 9:35 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 113,750 | $0 | 113,750 (Direct) | View |
| 2021-11-12 Option Award | 2021-11-16 4:34 pm | N/A 2031-11-11 | Aeglea BioTherapeutics Inc. | AGLE | Smith Hunter C Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-04-21 Exercise | 2021-04-23 06:08 am | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 5,000 | $6.88 | 201,744 (Direct) | View |
| 2021-04-21 Exercise | 2021-04-23 06:08 am | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 5,000 | $0 | 201,744 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-16 5:27 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 65,625 | $0 | 65,625 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-20 4:05 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 4,000 | $6.88 | 201,744 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-20 4:05 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 4,000 | $0 | 201,744 (Direct) | View |
| 2020-07-20 Option Award | 2020-07-21 5:16 pm | N/A 2030-07-19 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:05 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C CFO and Interim CEO | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-03-30 Exercise | 2020-03-31 6:00 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C CFO and Interim CEO | 3,900 | $6.88 | 201,744 (Direct) | View |
| 2020-03-30 Exercise | 2020-03-31 6:00 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C CFO and Interim CEO | 3,900 | $0 | 201,744 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 4:16 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 3,500 | $6.88 | 201,744 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 4:16 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 3,500 | $0 | 201,744 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:23 pm | N/A 2030-02-13 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 82,000 | $0 | 82,000 (Direct) | View |
| 2020-01-28 Exercise | 2020-01-29 4:00 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 6,250 | $6.88 | 201,744 (Direct) | View |
| 2020-01-28 Exercise | 2020-01-29 4:00 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 6,250 | $0 | 201,744 (Direct) | View |
| 2019-12-30 Disposition | 2019-12-30 4:47 pm | N/A N/A | GENESEE & WYOMING INC | GWR | Smith Hunter C Director | 11,824 | $112 | 0 (Direct) | View |